WebMar 15, 2024 · Opthea shareholders have experienced a volatile year, with some significant price swings higher and lower. Over the past 12 months, the Opthea share price is down 9%. That compares to a 38% gain on the All Ordinaries Index (ASX: XAO). Opthea shares have slipped 12% so far in 2024. WebMar 30, 2024 · The Company’s Phase 2a DME trial is a randomized, dose expansion study designed to enrol at least 108 evaluable patients diagnosed with persistent centre-involved DME despite regular ...
OPT: Opthea Ltd - Stock Price, Quote and News - CNBC
WebMay 5, 2024 · Opthea (ASX:OPT; Nasdaq:OPT) is a biopharmaceutical company developing novel therapies to address the unmet need in the treatment of highly prevalent and progressive retinal diseases, including... WebThe Company was formed in October 1984 for a total consideration of 2,000,000 options, following which a public issue of 5,000,000 20 cent ord. shares with 1:1 attaching 1989 options at 1 cent each, raised $1,050,000. The Company's securities were granted Official Quotation on the Melbourne Second Board on 28/03/1985. dauphin island in alabama
Opthea Ltd (ASX:OPT) Share Price - Market Index
WebSep 9, 2024 · Stockbroker Bell Potter’s Tanushree Jain reckons $4.44 is a fair estimate of the value of Opthea shares, taking into account what industry majors have paid for other biotech juniors working up potentially valuable ideas in the same field. In mid-August she hiked her value of Opthea shares from $2.79 earlier. WebOct 16, 2024 · Opthea (ASX:OPT, Nasdaq: OPT) is a biopharmaceutical company developing a novel therapy to address the unmet need in the treatment of highly prevalent and progressive retinal diseases,... WebApr 14, 2024 · Opthea Limited ($ASX:OPT)'s share price experienced a 0.6% increase on Thursday, reaching a high of $3.84 before closing the trading day at $3.55. This marks black american during great depression